[{"Assets_0_Q1_USD":1469492000.0,"CommonStockSharesOutstanding_0_Q1_shares":86997000.0,"EarningsPerShareBasic_1_Q1_USD":1.02,"EarningsPerShareDiluted_1_Q1_USD":1.01,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":34898000.0,"NetIncomeLoss_1_Q1_USD":89451000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":537656000.0,"StockholdersEquity_0_Q1_USD":-49272000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":88944000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":87331000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20180504"}]